Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient’s own T-cells to target tumors. However, they can cause rare, but potentially fatal cardiac inflammation known as ICI-myocarditis. This is particularly…
Continue Reading
News Source: medicalxpress.com
Leave a Reply